SCOPUS 정보 검색 플랫폼

Volumn 92, Issue 2, 2001, Pages 207-217

Dose-escalated cyclophosphamide, doxorubicin, vincristine, prednisone, and etoposide (CHOPE) chemotherapy for patients with diffuse lymphoma: Cancer and Leukemia Group B studies 8852 and 8854

(10) Bartlett, Nancy L a Petroni, Gina R b Parker, Barbara A c Wagner, Nina D a Gockerman, Jon P d Omura, George A e Canellos, George P f Robertcooper, M g Johnson, Jeffrey L b Peterson, Bruce A h

a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE (United States)

b Statistical Center (United States)

c UNIVERSITY OF CALIFORNIA (United States)

d DUKE UNIVERSITY MEDICAL CENTER (United States)

e UNIVERSITY OF ALABAMA AT BIRMINGHAM (United States)

f DANA FARBER CANCER INSTITUTE (United States)

g WAKE FOREST SCHOOL OF MEDICINE (United States)

h UNIVERSITY OF MINNESOTA (United States)

Author keywords

Cyclophosphamide, doxorubicin, vincristine, prednisone, and etoposide; Dose escalation; Granulocyte colony stimulating factor; Non Hodgkin lymphoma, cyclophosphamide, doxorubicin, vincristine, and prednisone

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; PREDNISONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; VINCRISTINE;

ADULT; AGED; ALOPECIA; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HUMAN; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MAXIMUM TOLERATED DOSE; NAUSEA; NEUTROPENIA; NONHODGKIN LYMPHOMA; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; THROMBOCYTOPENIA; TREATMENT OUTCOME; VOMITING;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYCLOPHOSPHAMIDE; DISEASE-FREE SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; ETOPOSIDE; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; LYMPHOMA, LARGE-CELL, DIFFUSE; LYMPHOMA, LARGE-CELL, IMMUNOBLASTIC; LYMPHOMA, MIXED-CELL, DIFFUSE; LYMPHOMA, SMALL CLEAVED-CELL, DIFFUSE; MALE; MIDDLE AGED; NEUTROPENIA; PREDNISONE; TREATMENT OUTCOME; VINCRISTINE;

EID: 0035878808 PISSN: 0008543X EISSN: None Source Type: Journal
DOI: 10.1002/1097-0142(20010715)92:2<207::AID-CNCR1311>3.0.CO;2-D Document Type: Article

Times cited : (30)

References (19)

1
- 0027394689
- Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma
- (1993) N Engl J Med , vol.328 , pp. 1002-1006
- Fisher, R.I.¹ Gaynor, E.R.² Dahlberg, S.³ Oken, M.M.⁴ Grogan, T.M.⁵ Mize, E.M.⁶

2
- 0019254230
- VP-16-213 in combination with cyclophosphamide, doxorubicin, vincristine and prednisone in the treatment of non-Hodgkin's lymphomas
- (1980) Cancer Treat Rep , vol.64 , pp. 1135-1137
- Hansen, M.M.¹ Bloomfield, C.D.² Jorgensen, J.³ Ersboll, J.⁴ Pederson-Bjergaard, J.⁵ Blom, J.⁶

3
- 7844226294
- Addition of etoposide to CHOP chemotherapy in untreated patients with high-grade non-Hodgkin's lymphoma
- (1998) Ann Oncol , vol.9 , pp. 1213-1217
- Celsing, F.¹ Widell, S.² Merk, K.³ Bernell, P.⁴ Grimfors, G.⁵ Hedlund, A.⁶

4
- 0020033928
- The Non-Hodgkin's Lymphoma Classification Project: National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: Summary and description of a working formulation for clinical usage
- (1982) Cancer , vol.49 , pp. 2112-2135

5
- 33845382806
- Nonparametric estimation from incomplete observations
- (1958) J Am Stat Assoc , vol.53 , pp. 457
- Kaplan, E.I.¹ Meier, P.²

6
- 0027444652
- The International Non-Hodgkin's Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin's lymphoma
- (1993) N Engl J Med , vol.329 , pp. 987-994

7
- 0029587694
- Vincristine, doxorubicin, cyclophosphamide, prednisone, and etoposide (VACPE) in high-grade non-Hodgkin's lymphoma - A multicenter Phase II study
- (1995) Ann Oncol , vol.6 , pp. 1019-1024
- Bergmann, L.¹ Karakas, T.² Lautenschlager, G.³ Jager, E.⁴ Knuth, A.⁵ Mitrou, P.S.⁶

8
- 0028203625
- Intensification of CHOEP regimen for high-grade non-Hodgkin's lymphoma by G-CSF: Feasibility of a 14-day regimen
- (1994) Onkologie , vol.17 , pp. 69-71
- Trumper, L.¹ Renner, C.² Nahler, M.³ Engert, A.⁴ Koch, P.⁵ Diehl, V.⁶

9
- 0028005329
- Randomised comparison of CHOEP versus alternating hCHOP/IVEP for high-grade non-Hodgkin's lymphomas: Treatment results and prognostic factor analysis in a multi-centre trial
- (1994) Ann Oncol , vol.5 , pp. 49-55
- Koppler, H.¹ Pfluger, K.-H.² Eschenbach, I.³ Pfab, R.⁴ Birkmann, J.⁵ Zeller, W.⁶

10
- 0028064764
- A revised European-American Classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group
- (1994) Blood , vol.84 , Issue.5 , pp. 1361-1392
- Harris, N.L.¹ Jaffe, E.S.² Stein, H.³ Banks, P.M.⁴ Chan, J.K.C.⁵ Cleary, M.L.⁶

11
- 0029915309
- Phase I trial of dose escalation with growth factor support in patients with previously untreated diffuse aggressive lymphomas: Determination of the maximum-tolerated dose of ProMACE-CytaBOM
- (1996) J Clin Oncol , vol.14 , pp. 1275-1281
- Gordon, L.I.¹ Andersen, J.² Haberrnann, T.M.³ Winter, J.N.⁴ Glick, J.⁵ Schilder, R.J.⁶

12
- 0033570984
- A Phase II trial of 200% ProMACE-CytaBOM in patients with previously untreated aggressive lymphomas: Analysis of response, toxicity, and dose intensity
- (1999) Blood , vol.94 , pp. 3307-3314
- Gordon, L.I.¹ Young, M.² Weller, E.³ Habermann, T.M.⁴ Winter, J.N.⁵ Glick, J.⁶

13
- 0028793717
- High-dose CHOP as initial therapy for patients with poor-prognosis aggressive non-Hodgkin's lymphoma: A dose-finding pilot study
- (1995) J Clin Oncol , vol.13 , pp. 2916-2923
- Shipp, M.A.¹ Neuberg, D.² Janicek, M.³ Canellos, G.P.⁴ Shulman, L.N.⁵

14
- 0003268631
- High dose CHOP induction therapy for poor prognosis aggressive NHL (CALGB 9351): FFP differs at high and low accrual institutions
- (1998) Blood , vol.92
- Shipp, M.¹ Niedzwiecki, D.² Johnson, J.³ Janicek, M.⁴ Barcos, M.⁵ Gockerman, J.⁶

15
- 0032978073
- Dose-escalation of CHOP in non-Hodgkin's lymphoma
- (1999) Ann Oncol , vol.10 , pp. 519-525
- Santoro, A.¹ Balzarotti, M.² Tondini, C.³ Zanini, M.⁴ Giardini, R.⁵ Latteri, F.⁶

16
- 85112371009
- Randomized trial of granulocyte-colony stimulating factor (G-CSF) added to CHOP in elderly patients with aggressive non-Hodgkin's lymphoma
- (2000) Blood , vol.96 , Issue.10
- Doorduijn, J.K.¹ Van der Holt, B.² Van der Hem, K.G.³ Van Imhof, G.W.⁴ Kramer, M.H.H.⁵ Van Oers, M.H.J.⁶

17
- 0028790440
- Autologous bone marrow transplantation as compared with salvage chemotherapy in relapsed of chemotherapy-sensitive non-Hodgkin's lymphoma
- (1995) N Engl J Med , vol.333 , Issue.230 , pp. 1540-1545
- Philip, T.¹ Guglielmi, C.² Hagenbeek, A.³ Somers, R.⁴ Van Der Lelie, H.⁵ Bron, D.⁶

18
- 0032951328
- International consensus conference on high-dose therapy with hematopoietic stem cell transplantation in aggressive non-Hodgkin's lymphomas: Report of the jury
- (1999) J Clin Oncol , vol.17 , pp. 423-429
- Shipp, M.A.¹ Abeloff, M.D.² Antman, K.H.³ Carroll, G.⁴ Hagenbeek, A.⁵ Loeffler, M.⁶

19
- 0003209414
- Failure of first-line inductive high-dose chemotherapy (HDC) in poor risk patients (PTS) with aggressive lymphoma: Updated results of the randomized LNH93-3 study
- (1997) Blood , vol.10 , Issue.SUPPL. 1
- Reyes, F.¹ Lepage, E.² Morel, P.³ Lederlin, P.⁴ Coiffier, B.⁵ Tilly, H.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.